Wengang Jian
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC.
Journal: Cell death & disease
Published: December 23, 2022
Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments.
Journal: Frontiers in immunology
Published: October 26, 2022
RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNA.
Journal: Molecular carcinogenesis
Published: August 28, 2022
FBXL6 depletion restrains clear cell renal cell carcinoma progression.
Journal: Translational oncology
Published: May 07, 2022
A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma.
Journal: BMC medical genomics
Published: October 19, 2021
RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Journal: Molecular medicine reports
Published: June 29, 2020
Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 13, 2019
α-1,2-Mannosidase MAN1C1 Inhibits Proliferation and Invasion of Clear Cell Renal Cell Carcinoma.
Journal: Journal of Cancer
Published: June 05, 2018
The effect of Hsa_circ_0001451 in clear cell renal cell carcinoma cells and its relationship with clinicopathological features.
Journal: Journal of Cancer
Published: March 06, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026